Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063437 · ClinicalTrials.gov registry record · Phase 2
A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization
A Phase 2 study, sponsored by Microbiome Health Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT03063437 is a Phase 2 study that has completed, run by Microbiome Health Research Institute. The registered enrollment target is 9 participants.
The verdict
NCT03063437, a Phase 2 study, has completed, sponsored by Microbiome Health Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
The objective of this study is to provide preliminary insight into the safety and efficacy of fecal microbiota transplantation (FMT) for the eradication of gastrointestinal carriage of vancomycin-resistant Enterococcus.
Interventions
- BIOLOGICAL Encapsulated fecal microbiota preparation
- BIOLOGICAL Encapsulated placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-08-17 |
| Est. Completion | 2019-02-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03063437
The ClinicalTrials.gov registry entry for NCT03063437 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Microbiome Health Research Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Encapsulated fecal microbiota preparation is the first listed.
NCT03063437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03063437 about?
NCT03063437 is a clinical study titled "A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization". The objective of this study is to provide preliminary insight into the safety and efficacy of fecal microbiota transplantation (FMT) for the eradication of gastrointestinal carriage of vancomycin-resistant Enterococcus.
What is the current status of trial NCT03063437?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2017-08-17. Estimated completion is 2019-02-26.
What interventions are being tested in trial NCT03063437?
The interventions under investigation include: Encapsulated fecal microbiota preparation (BIOLOGICAL), Encapsulated placebo (BIOLOGICAL).
Who is sponsoring clinical trial NCT03063437?
This trial is sponsored by Microbiome Health Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.